|
|
SMALL MOLECULE THERAPEUTICS FOR ALZHEIMER'S DISEASE |
| 1R43AG055182-01 |
DEWJI, NAZNEEN N |
NIA |
2016 |
|
|
ANTI-RPS23RG1 NANOANTIBODY AS NOVEL THERAPEUTIC AND RESEARCH REAGENTS FOR ALZHEIMER’S DISEASE. |
| 1R43AG055208-01 |
TU, SHICHUN |
NIA |
2016 |
|
|
NOVEL ASSAYS FOR ASSESSING PROTEIN-PROTEIN INTERACTIONS IN ALZHEIMER'S DISEASE |
| 1R43AG055250-01 |
BUTT, TAUSEEF R. |
NIA |
2016 |
|
|
A NOVEL NEUROPROTECTIVE THERAPY FOR ALZHEIMER’S DISEASE |
| 1R44AG053084-01 |
ABRAHAM, MENACHEM |
NIA |
2016 |
|
|
SOFTWARE PLATFORM FOR ANALYZING ALZHEIMER'S AND PARKINSON'S FMRI CONNECTOMES |
| 1R44AG054405-01 |
SHANNON, WILLIAM D. |
NIA |
2016 |
|
|
2-HYDROXYBENZYLAMINE FOR THE PREVENTION OF ALZHEIMER'S DISEASE: INITIAL EVALUATION IN HUMANS |
| 1R44AG055184-01 |
RATHMACHER, JOHN A |
NIA |
2016 |
|
|
TARGET ENGAGEMENT BIOMARKERS FOR ALZHEIMER'S THERAPEUTICS |
| 1R44AG055247-01 |
CATALANO, SUSAN M |
NIA |
2016 |
|
|
DISCOVERY OF PROBES THAT ENHANCE EXPRESSION OF THE NEUROPROTECTIVE PROTEIN KLOTHO |
| 1R56AG051638-01A1 |
ABRAHAM, CARMELA R |
NIA |
2016 |
|
|
IN VIVO AND IN VITRO SYSTEMS TO VALIDATE GERONIC PROTEINS AND THEIR MECHANISMS OF ACTION |
| 1R56AG052986-01 |
HORVATH, TAMAS L |
NIA |
2016 |
|
|
MOLECULAR MECHANISMS OF GANGLION CELL LOSS IN ALZHEIMERS DISEASE |
| 1R56AG053369-01 |
IVANOV, DMITRY V |
NIA |
2016 |
